Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial

Daniel A Rossignol1, Lanier W Rossignol, Scott Smith

  • 1International Child Development Resource Center, Melbourne, FL, USA. rossignolmd@gmail.com

BMC Pediatrics
|March 17, 2009
PubMed

Insights

Hyperbaric treatment significantly improved autism symptoms in children, including language and social interaction. This controlled study found the therapy safe and effective for enhancing overall functioning and sensory awareness.

Area of Science:

  • Neurology
  • Pediatrics
  • Hyperbaric Medicine

Background:

  • Previous uncontrolled studies suggested hyperbaric treatment benefits children with autism.
  • A controlled evaluation was needed to confirm these findings.

Purpose of the Study:

  • To assess the efficacy of hyperbaric treatment in children with autism through a multicenter, randomized, double-blind, controlled trial.

Main Methods:

  • 62 children (ages 2-7) with autism received 40 hourly sessions of either hyperbaric treatment (1.3 atm, 24% oxygen) or a control (1.03 atm, 21% oxygen).
  • Outcomes were measured using the Clinical Global Impression (CGI) scale, Aberrant Behavior Checklist (ABC), and Autism Treatment Evaluation Checklist (ATEC).

Main Results:

  • The hyperbaric group showed significant improvements in physician-rated CGI scores for overall functioning, receptive language, social interaction, and eye contact.
  • Parental CGI scores also improved significantly in the treatment group for overall functioning, receptive language, and eye contact.
  • Significant improvements were noted in the treatment group on the ABC (total score, irritability, stereotypy, hyperactivity, speech) and ATEC (sensory/cognitive awareness).

Conclusions:

  • Hyperbaric treatment at 1.3 atm and 24% oxygen for 40 sessions led to significant improvements in children with autism.
  • Improvements were observed in overall functioning, receptive language, social interaction, eye contact, and sensory/cognitive awareness compared to the control group.
  • The treatment was found to be safe and well-tolerated, with greater benefits seen in children over age 5 and those with lower initial autism severity.
Abstract

Related Concept Videos